𝐌𝐨𝐫𝐞 𝐭𝐡𝐚𝐧 𝟒𝟎 𝐲𝐞𝐚𝐫𝐬 𝐨𝐟 𝐓𝐫𝐮𝐬𝐭. 𝐌𝐚𝐝𝐞 𝐢𝐧 𝐀𝐟𝐫𝐢𝐜𝐚, 𝐟𝐨𝐫 𝐀𝐟𝐫𝐢𝐜𝐚.

For over four decades, 𝐒𝐡𝐚𝐥𝐢𝐧𝐚 𝐇𝐞𝐚𝐥𝐭𝐡𝐜𝐚𝐫𝐞 has delivered quality, affordable medicines across Africa. The 𝐃𝐞𝐦𝐨𝐜𝐫𝐚𝐭𝐢𝐜 𝐑𝐞𝐩𝐮𝐛𝐥𝐢𝐜 𝐨𝐟 𝐂𝐨𝐧𝐠𝐨 was our first market, and today we are deepening that commitment with a world-class pharmaceutical manufacturing facility in 𝐊𝐢𝐧𝐬𝐡𝐚𝐬𝐚.

Through Laboratoire Shalina République Démocratique du Congo (LSRDC), we are investing USD 25 million in a new 30,000 sqm greenfield facility within the 𝐀𝐫𝐢𝐬𝐞 𝐊𝐢𝐧-𝐌𝐚𝐥𝐞𝐛𝐨 𝐒𝐄𝐙.

The state-of-the-art plant will manufacture over 𝟏 𝐛𝐢𝐥𝐥𝐢𝐨𝐧 𝐭𝐚𝐛𝐥𝐞𝐭𝐬, 𝟔𝟎𝟎 𝐦𝐢𝐥𝐥𝐢𝐨𝐧 𝐜𝐚𝐩𝐬𝐮𝐥𝐞𝐬, 𝐚𝐧𝐝 𝟐𝟎 𝐦𝐢𝐥𝐥𝐢𝐨𝐧 𝐬𝐲𝐫𝐮𝐩 𝐛𝐨𝐭𝐭𝐥𝐞𝐬 𝐚𝐧𝐧𝐮𝐚𝐥𝐥𝐲, bringing trusted brands such as Amidol, Ibucap, Anaflam, Tanzol and Hemoforce closer to patients.

The facility will strengthen local manufacturing, create skilled employment, and include a dedicated training institute to build a highly qualified local workforce to international standards.

“𝑊𝑒 𝑎𝑟𝑒 𝑝𝑟𝑜𝑢𝑑 𝑡𝑜 𝑏𝑒 𝑖𝑛𝑣𝑒𝑠𝑡𝑖𝑛𝑔 𝑖𝑛 𝑎 𝑛𝑒𝑤 𝑓𝑎𝑐𝑖𝑙𝑖𝑡𝑦 𝑡ℎ𝑎𝑡 𝑤𝑖𝑙𝑙 𝑞𝑢𝑎𝑙𝑖𝑓𝑦 𝑓𝑜𝑟 𝑊𝑒𝑠𝑡𝑒𝑟𝑛 𝑚𝑎𝑟𝑘𝑒𝑡𝑠 𝑎𝑛𝑑 𝑦𝑒𝑡 𝑖𝑡 𝑤𝑖𝑙𝑙 𝑠𝑒𝑟𝑣𝑒 𝑡ℎ𝑒 𝑙𝑜𝑐𝑎𝑙 𝑝𝑜𝑝𝑢𝑙𝑎𝑡𝑖𝑜𝑛 𝑜𝑓 𝐾𝑖𝑛𝑠ℎ𝑎𝑠𝑎 𝑎𝑛𝑑 𝑡ℎ𝑒 𝑤𝑖𝑑𝑒𝑟 𝑟𝑒𝑔𝑖𝑜𝑛. 𝑊𝑒 𝑎𝑟𝑒 𝑐𝑜𝑚𝑚𝑖𝑡𝑡𝑒𝑑 𝑡𝑜 𝑟𝑎𝑖𝑠𝑖𝑛𝑔 𝑡ℎ𝑒 𝑏𝑎𝑟 𝑎𝑛𝑑 𝑏𝑒𝑖𝑛𝑔 𝑡ℎ𝑒 𝑏𝑒𝑠𝑡 𝑓𝑎𝑐𝑖𝑙𝑖𝑡𝑦 𝑖𝑛 𝑡ℎ𝑒 𝐷𝑅𝐶.”
— Abbas Virji, Managing Director

“𝐴𝑓𝑟𝑖𝑐𝑎 ℎ𝑎𝑠 𝑎𝑙𝑤𝑎𝑦𝑠 𝑏𝑒𝑒𝑛 𝑎𝑡 𝑡ℎ𝑒 ℎ𝑒𝑎𝑟𝑡 𝑜𝑓 𝑆ℎ𝑎𝑙𝑖𝑛𝑎 𝐻𝑒𝑎𝑙𝑡ℎ𝑐𝑎𝑟𝑒’𝑠 𝑗𝑜𝑢𝑟𝑛𝑒𝑦. 𝑇ℎ𝑖𝑠 𝑓𝑎𝑐𝑖𝑙𝑖𝑡𝑦 𝑖𝑠 𝑜𝑢𝑟 𝑐𝑜𝑚𝑚𝑖𝑡𝑚𝑒𝑛𝑡 𝑡𝑜 𝑡ℎ𝑒 𝑐𝑜𝑚𝑚𝑢𝑛𝑖𝑡𝑖𝑒𝑠 𝑤𝑒 𝑠𝑒𝑟𝑣𝑒 — 𝑏𝑟𝑖𝑛𝑔𝑖𝑛𝑔 𝑡𝑟𝑢𝑠𝑡𝑒𝑑, 𝑎𝑓𝑓𝑜𝑟𝑑𝑎𝑏𝑙𝑒 𝑚𝑒𝑑𝑖𝑐𝑖𝑛𝑒𝑠 𝑐𝑙𝑜𝑠𝑒𝑟 𝑡𝑜 𝑡ℎ𝑒 𝑝𝑒𝑜𝑝𝑙𝑒 𝑤ℎ𝑜 𝑛𝑒𝑒𝑑 𝑡ℎ𝑒𝑚 𝑚𝑜𝑠𝑡.”
— Shalina Clifford, Group CEO

“𝑇ℎ𝑖𝑠 𝑓𝑎𝑐𝑖𝑙𝑖𝑡𝑦 𝑚𝑎𝑟𝑘𝑠 𝑎 𝑚𝑖𝑙𝑒𝑠𝑡𝑜𝑛𝑒 𝑖𝑛 𝐴𝑓𝑟𝑖𝑐𝑎’𝑠 𝑝ℎ𝑎𝑟𝑚𝑎𝑐𝑒𝑢𝑡𝑖𝑐𝑎𝑙 𝑓𝑢𝑡𝑢𝑟𝑒 — 𝑒𝑛𝑎𝑏𝑙𝑖𝑛𝑔 𝑙𝑜𝑐𝑎𝑙 𝑖𝑛𝑛𝑜𝑣𝑎𝑡𝑖𝑜𝑛, 𝑠𝑐𝑎𝑙𝑖𝑛𝑔 𝑖𝑚𝑝𝑎𝑐𝑡, 𝑎𝑛𝑑 𝑠𝑡𝑟𝑒𝑛𝑔𝑡ℎ𝑒𝑛𝑖𝑛𝑔 𝑤𝑜𝑟𝑙𝑑-𝑐𝑙𝑎𝑠𝑠 𝑚𝑎𝑛𝑢𝑓𝑎𝑐𝑡𝑢𝑟𝑖𝑛𝑔 𝑡ℎ𝑟𝑜𝑢𝑔ℎ 𝑜𝑢𝑟 𝑝𝑎𝑟𝑡𝑛𝑒𝑟𝑠ℎ𝑖𝑝 𝑤𝑖𝑡ℎ 𝑡ℎ𝑒 𝑣𝑖𝑠𝑖𝑜𝑛𝑎𝑟𝑦 𝑆ℎ𝑎𝑙𝑖𝑛𝑎 𝐺𝑟𝑜𝑢𝑝.”
— Abhishek Aggarwal, Director, Airtech Systems

Following Nigeria and Angola, this WHO-cGMP-compliant facility marks the next chapter of our growth in Africa.

𝐐𝐮𝐚𝐥𝐢𝐭𝐲 𝐲𝐨𝐮 𝐜𝐚𝐧 𝐭𝐫𝐮𝐬𝐭 — 𝐛𝐮𝐢𝐥𝐭 𝐜𝐥𝐨𝐬𝐞 𝐭𝐨 𝐭𝐡𝐞 𝐩𝐞𝐨𝐩𝐥𝐞 𝐰𝐞 𝐬𝐞𝐫𝐯𝐞.